Treating rheumatoid arthritis using fibroblast-activated protein-α-responsive micelles through a cascade control program
{{output}}
Rheumatoid arthritis (RA), a chronic autoimmune disorder affecting 1% globally, urgently demands advanced therapies to overcome the systemic toxicity and limited efficacy of conventional glucocorticoids like dexamethasone (Dex). In this study, we constructed L... ...
